BR6913348D0 - Forno eletrico aperfeicoado para a fusao continua de produtos solidos - Google Patents

Forno eletrico aperfeicoado para a fusao continua de produtos solidos

Info

Publication number
BR6913348D0
BR6913348D0 BR213348/69A BR21334869A BR6913348D0 BR 6913348 D0 BR6913348 D0 BR 6913348D0 BR 213348/69 A BR213348/69 A BR 213348/69A BR 21334869 A BR21334869 A BR 21334869A BR 6913348 D0 BR6913348 D0 BR 6913348D0
Authority
BR
Brazil
Prior art keywords
electric oven
solid products
continuous fusing
perfected electric
perfected
Prior art date
Application number
BR213348/69A
Other languages
English (en)
Portuguese (pt)
Inventor
J Antoine
Original Assignee
Siderurgie Fse Inst Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siderurgie Fse Inst Rech filed Critical Siderurgie Fse Inst Rech
Publication of BR6913348D0 publication Critical patent/BR6913348D0/pt

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00—Arrangement of elements for electric heating in or on furnaces
    • F27D11/08—Heating by electric discharge, e.g. arc discharge
    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21C—PROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL; TREATMENT IN MOLTEN STATE OF FERROUS ALLOYS
    • C21C5/00—Manufacture of carbon-steel, e.g. plain mild steel, medium carbon steel or cast steel or stainless steel
    • C21C5/52—Manufacture of steel in electric furnaces
    • C21C5/5252—Manufacture of steel in electric furnaces in an electrically heated multi-chamber furnace, a combination of electric furnaces or an electric furnace arranged for associated working with a non electric furnace
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00—Arrangement of elements for electric heating in or on furnaces
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D3/00—Charging; Discharging; Manipulation of charge
    • F27D3/18—Charging particulate material using a fluid carrier

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Vertical, Hearth, Or Arc Furnaces (AREA)
  • Furnace Details (AREA)
  • Discharge Heating (AREA)
BR213348/69A 1968-10-17 1969-10-16 Forno eletrico aperfeicoado para a fusao continua de produtos solidos BR6913348D0 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR170197 1968-10-17

Publications (1)

Publication Number Publication Date
BR6913348D0 true BR6913348D0 (pt) 1973-01-02

Family

ID=8655735

Family Applications (1)

Application Number Title Priority Date Filing Date
BR213348/69A BR6913348D0 (pt) 1968-10-17 1969-10-16 Forno eletrico aperfeicoado para a fusao continua de produtos solidos

Country Status (10)

Country Link
US (1) US3610795A (enExample)
JP (1) JPS4829422B1 (enExample)
BE (1) BE739974A (enExample)
BR (1) BR6913348D0 (enExample)
DE (1) DE1952407B2 (enExample)
ES (1) ES372628A1 (enExample)
FR (1) FR1601438A (enExample)
GB (1) GB1252310A (enExample)
LU (1) LU59646A1 (enExample)
SE (1) SE364311B (enExample)

Families Citing this family (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891427A (en) * 1972-10-12 1975-06-24 Lectromelt Corp Method for melting prereduced ore and scrap
SE378735B (enExample) * 1972-11-17 1975-09-08 Asea Ab
FR2220584B1 (enExample) * 1973-03-05 1976-05-21 Siderurgie Fse Inst Rech
US3939297A (en) * 1973-12-07 1976-02-17 Chase Brass & Copper Co., Incorporated Stoker feed system
SE7503782L (sv) * 1975-04-02 1976-10-03 Asea Ab Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
DE2632707C3 (de) * 1976-07-21 1983-04-07 Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
US4133967A (en) * 1977-06-24 1979-01-09 The United States Of America As Represented By The Secretary Of The Interior Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
US4447906A (en) * 1981-02-02 1984-05-08 Lectromelt Corporation Arc furnace for producing aluminum
SE8303372L (sv) * 1983-06-14 1984-12-15 Asea Ab Ugnsanordning for smeltning av metaller eller metallegeringar
AT384669B (de) * 1986-03-17 1987-12-28 Voest Alpine Ag Anlage zur herstellung von stahl aus schrott
CA1311787C (en) * 1986-06-24 1992-12-22 Masahisa Tate Method of bottom blowing operation of a steel making electric furnace
FR2705767B1 (fr) * 1993-05-27 1995-07-21 Lorraine Laminage Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
DE4339226A1 (de) * 1993-11-15 1995-05-18 Mannesmann Ag Verfahren und Vorrichtung zur Wertstoffgewinnung
LU88517A7 (fr) * 1993-12-15 1996-02-01 Wurth Paul Sa Dispositif de chargement d'un four électrique
AT404841B (de) 1995-04-10 1999-03-25 Voest Alpine Ind Anlagen Anlage und verfahren zum herstellen von eisenschmelzen
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
ATE301273T1 (de) * 1999-05-18 2005-08-15 Danieli Technology Inc Elektrischer lichtbogenofen und verfahren zum kontinuierlichen chargieren
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
CA2415815A1 (en) * 2000-07-06 2002-01-17 Nigel H. Greig Tetrahydrobenzothiazole analogues as neuroprotective agents
US6642002B2 (en) 2000-07-17 2003-11-04 Vanderbilt University Method of diagnosing pulmonary hypertension
JP5305553B2 (ja) 2000-10-12 2013-10-02 ユニバーシティー オブ ロチェスター 癌細胞の増殖を阻害する組成物
AU2002303277A1 (en) * 2001-04-06 2002-10-21 Vladimir Larionov Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells
BR0213043A (pt) * 2001-10-01 2004-10-05 Univ Vanderbilt Métodos de tratar ou prevenir dusfunção contrátil miocárdica após infarto do miocárdio em um sujeito, de tratar ou prevenir cardiomiopatia dilatada em um sujeito e de incrementar contratilidade miocárdica em um sujeito, animal transgênico, e, método de identificar um composto que pode tratar doença estrutural do coração
US20040248289A1 (en) * 2001-10-04 2004-12-09 Vladimir Noskov Tandem repeat markers
EP2311852A1 (en) 2002-02-06 2011-04-20 Stasys Technologies, Inc. Anti-infarction molecules
JP4689268B2 (ja) 2002-06-14 2011-05-25 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ Ｉｌ−１３およびｎｋ−ｔ細胞に関する、結腸炎を処置および予防する方法
CA2495478A1 (en) 2002-08-05 2004-02-12 University Of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
EP2292259A3 (en) 2002-11-15 2011-03-23 MUSC Foundation For Research Development Complement receptor 2 targeted complement modulators
EP2410332A1 (en) 2002-11-21 2012-01-25 The University Of Utah Method for identifying purinergic modulators of the olfactory system
AU2005207002B2 (en) 2004-01-21 2011-03-17 University Of Utah Research Foundation Mutant sodium channel Nav1.7 and methods related thereto
AU2005220874B2 (en) 2004-03-04 2010-12-23 Vanderbilt University Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
EP1734821A4 (en) * 2004-04-14 2011-07-06 Uab Research Foundation ACTIVATORS OF HEXOSAMIN BINOSYNTHESIS AS AN INHIBITORS FOR INDUCED DAMAGE CAUSED BY ISCHEMIC SHOCK OR HEMORRHAGIC SHOCK
US20050244335A1 (en) * 2004-05-03 2005-11-03 Rinehart John J Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
CA2566703A1 (en) 2004-05-11 2005-11-24 Vishwa Deep Dixit Methods of inhibiting proinflammatory cytokine expression using ghrelin
JP2008500064A (ja) 2004-05-21 2008-01-10 ザ ユーエービー リサーチ ファウンデーション 可変性リンパ球受容体、その関連ポリペプチドおよび核酸、ならびにその使用
CA2588649A1 (en) * 2004-11-18 2006-05-26 University Of Rochester Methods and compositions related to esculentoside a
EP2289535B8 (en) 2004-12-21 2018-08-08 MUSC Foundation for Research Development Compositions and methods for promoting wound healing and tissue regeneration
ES2412005T3 (es) 2005-04-15 2013-07-09 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services Tratamiento y prevención de la enfermedad intestinal inflamatoria que implica IL-13 y células NKT
EP2371843B1 (en) 2005-05-19 2014-09-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
US8859585B2 (en) 2005-05-25 2014-10-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Scopolamine for the treatment of depression and anxiety
MX338235B (es) 2005-06-07 2016-04-08 Dsm Nutritional Products Ag Microorganismos eucarioticos para producir lipidos y antioxidantes.
EP2189522A1 (en) 2005-10-14 2010-05-26 MUSC Foundation For Research Development Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
US8080534B2 (en) 2005-10-14 2011-12-20 Phigenix, Inc Targeting PAX2 for the treatment of breast cancer
EP3088522B1 (en) 2005-12-29 2017-11-29 The Regents of the University of California Methods and compositions related to mutant kunitz domain i of tfpi-2
WO2007081792A2 (en) 2006-01-05 2007-07-19 University Of Utah Research Foundation Methods and compositions related to improving properties of pharmacological agents targeting nervous system
CA2638911C (en) * 2006-02-06 2018-01-23 Burnham Institute For Medical Research Methods and compositions related to targeting tumors and wounds
US8470965B2 (en) * 2006-03-01 2013-06-25 University Of Utah Research Foundation Methods and compositions related to cyclic peptide synthesis
WO2007103739A2 (en) * 2006-03-01 2007-09-13 The University Of Utah Research Foundation Methods and compositions related to cyclic peptide synthesis
NZ597557A (en) 2006-03-02 2013-10-25 Uab Research Foundation Mycobacterial disease detection, treatment, and drug discovery
JP5484049B2 (ja) 2006-07-10 2014-05-07 シナプシン ファーマシューティカルズ， インコーポレイテッド 神経学的障害を処置することおよび認知身体能力を強化することにおけるソレノプシンに関する組成物および方法ならびにその使用
NZ574473A (en) 2006-08-02 2013-02-22 Uab Research Foundation Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
EP2066812A4 (en) 2006-09-21 2010-04-28 Univ Rochester COMPOSITIONS AND METHODS RELATED TO PROTEIN SHIFT THERAPY FOR MYOTONE DYSTROPHY
EP2104516B1 (en) 2006-11-01 2015-01-07 University of Rochester Methods and compositions related to the structure and function of apobec3g
WO2008073441A2 (en) 2006-12-11 2008-06-19 University Of Utah Research Foundation Compositions and methods for treating pathologic angiogenesis and vascular permeability
WO2008089440A2 (en) 2007-01-18 2008-07-24 University Of Utah Research Foundation Compositions and methods for detecting, treating, or preventing reductive stress
EP2117576B1 (en) 2007-02-08 2014-04-16 University Of Utah Research Foundation Methods and compositions related to inhibition of viral entry
CN101801185A (zh) 2007-03-22 2010-08-11 耶鲁大学 与控制可变剪接的核糖开关有关的方法和组合物
EP2433496A1 (en) 2007-05-08 2012-03-28 Burnham Institute for Medical Research Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
EP2155894A4 (en) 2007-05-09 2010-08-18 Burnham Inst Medical Research HOST PROTEINAS AS A TARGET FOR A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL DISEASES
AU2007353789B2 (en) 2007-05-23 2014-05-22 The Uab Research Foundation Detoxified pneumococcal neuraminidase and uses thereof
WO2008156987A2 (en) 2007-05-29 2008-12-24 Yale University Riboswitches and methods and compositions for use of and with riboswitches
US20110130345A1 (en) 2007-06-21 2011-06-02 Baerbel Rohrer Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration
TW200916113A (en) 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
WO2009021163A2 (en) * 2007-08-08 2009-02-12 University Of Rochester Enhancing gene transfer
EP2190466A4 (en) * 2007-08-10 2011-12-21 Burnham Inst Medical Research Tissue-specific alkaline phosphatase (TNAP) activators and their use
US8501912B2 (en) 2007-12-03 2013-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Filipil compositions and methods for treating cancer
US20090233993A1 (en) * 2008-03-06 2009-09-17 Burnham Institute For Medical Research Compositions and methods for inhibiting gsk3 activity and uses thereof
EP2853897A1 (en) 2008-05-08 2015-04-01 University Of Utah Research Foundation Sensory receptors for chronic fatigue and pain and uses thereof
US20090291073A1 (en) * 2008-05-20 2009-11-26 Ward Keith W Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
US8816095B2 (en) * 2008-08-15 2014-08-26 Georgetown University Na channels, disease, and related assays and compositions
US20120070443A1 (en) 2008-12-02 2012-03-22 University Of Utah Research Foundation Pde1 as a target therapeutic in heart disease
US20100286762A1 (en) * 2009-03-18 2010-11-11 Musc Foundation For Research Development Compositions and Methods for Ameliorating Clinical Electrical Disturbances
EP2430161A1 (en) 2009-05-15 2012-03-21 Yale University Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
WO2011020107A2 (en) 2009-08-14 2011-02-17 Georgetown University Compositions and methods for detection and treatment of breast cancer
WO2011022502A1 (en) 2009-08-18 2011-02-24 Georgetown University Boronic acid compositions and methods related to cancer
US20110060000A1 (en) 2009-09-10 2011-03-10 Maurizio Grimaldi Acridine analogs in the treatment of gliomas
US20120321647A1 (en) 2010-01-12 2012-12-20 Yale University Structured rna motifs and compounds and methods for their use
WO2011112670A2 (en) 2010-03-09 2011-09-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
US20110262347A1 (en) 2010-04-08 2011-10-27 The Salk Institute For Biological Studies Methods and compositions for enhanced delivery of compounds
WO2012021554A1 (en) 2010-08-09 2012-02-16 Yale University Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
EP2651429B1 (en) 2010-12-15 2018-03-28 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
JP2014515012A (ja) 2011-03-15 2014-06-26 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション 血管関連黄斑症およびその症状の診断および治療方法
CA2868735C (en) 2011-03-28 2020-02-25 University Of Utah Research Foundation D-peptide conjugates comprising a membrane localizing potency-enhancing cargo molecule for inhibiting hiv entry
US10766937B2 (en) 2011-09-06 2020-09-08 Dana-Farber Cancer Institute, Inc. Compositions and methods of treating cancer
WO2014008475A2 (en) 2012-07-05 2014-01-09 The Ohio State University Compositions and methods related to viral vaccines
WO2014141111A1 (en) 2013-03-14 2014-09-18 Pluristem Ltd. Methods for prevention and treatment of graft-versus-host disease
US9783576B2 (en) 2013-06-11 2017-10-10 Sanford-Burnham Medical Research Institute Compositions and methods for targeted endometriosis treatment
WO2015003149A2 (en) 2013-07-05 2015-01-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Soluble cd33 for treating myelodysplastic syndromes (mds)
US9884895B2 (en) 2014-03-20 2018-02-06 The University Of North Carolina At Chapel Hill Methods and compositions for chimeric coronavirus spike proteins
US10189878B2 (en) 2014-09-24 2019-01-29 University Of Utah Research Foundation Ebolavirus pre-hairpin intermediate mimics and methods of use
EP3247807B1 (en) 2015-01-20 2020-12-16 Adcure Biotechnologies, LLC. Detargeted adenovirus variants and related methods
CA2977071A1 (en) 2015-02-20 2016-08-25 Board Of Regents, The University Of Texas System Methods and compositions for attenuated chlamydia as vaccine and vector
US10765754B2 (en) 2015-08-28 2020-09-08 Navigen, Inc. Compositions and methods related to inhibition of respiratory syncytial virus entry
US10487121B2 (en) 2016-01-07 2019-11-26 Navigen, Inc. D-peptide inhibitors of HIV entry and methods of use
CA3018058A1 (en) 2016-03-16 2017-09-21 Richard A. Shimkets Neutralizing monoclonal antibodies to il-25 and uses thereof
US10751340B2 (en) 2016-06-06 2020-08-25 University Of Central Florida Research Foundation, Inc. Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
JP7638061B2 (ja) 2016-07-29 2025-03-03 オハイオ ステート イノベーション ファウンデーション 腫瘍溶解性ウイルスによるＰＴＥＮ－Ｌｏｎｇの発現
KR20240042177A (ko) 2016-10-05 2024-04-01 유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 Nk 세포 및 항-pdl1 암 요법과 관련된 방법 및 조성물
US11696927B2 (en) 2017-02-28 2023-07-11 University Of Central Florida Research Foundation, Inc. PM21 particles to improve bone marrow homing of NK cells
CA3057680A1 (en) 2017-03-24 2018-09-27 Ohio State Innovation Foundation Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
BR112019020386A2 (pt) 2017-03-28 2020-06-09 Mayo Found Medical Education & Res vacinas de peptídeos de pd-1 humana e usos das mesmas
WO2018196782A1 (en) 2017-04-27 2018-11-01 The University Of Hong Kong Use of hcn inhibitors for treatment of cancer
KR20240132124A (ko) 2017-05-25 2024-09-02 유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 천연 살해 세포에 의해 사멸하는 종양 세포를 감작시키기 위한 신규한 종양용해 바이러스
US20200225244A1 (en) 2017-09-26 2020-07-16 Sanford Burnham Prebys Medical Discovery Institute Compositions and methods for assessing painful demyelinating and nondemyelinating diseases
WO2019118686A1 (en) 2017-12-13 2019-06-20 North Carolina State University Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use
WO2019195819A1 (en) 2018-04-06 2019-10-10 North Carolina State University Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy
WO2019217448A1 (en) 2018-05-07 2019-11-14 Georgia State University Research Foundation, Inc. Compositions and methods related to rhamnus prinoides (gesho) extract for the inhibition of polymicrobial biofilm formation
WO2019222503A1 (en) 2018-05-16 2019-11-21 Research Institute At Nationwide Children's Hospital Generation of knock-out primary and expanded human nk cells using cas9 ribonucleoproteins
US12453743B2 (en) 2018-05-30 2025-10-28 Direct Biologics, Llc Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
WO2020006493A1 (en) 2018-06-29 2020-01-02 North Carolina State University In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
US11331269B2 (en) 2018-09-06 2022-05-17 Massachusetts Institute Of Technology Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
EP3847650A1 (en) 2018-09-06 2021-07-14 The Broad Institute, Inc. Nucleic acid assemblies for use in targeted delivery
US20220267435A1 (en) 2018-10-03 2022-08-25 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
WO2020092057A1 (en) 2018-10-30 2020-05-07 Yale University Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
EP3873505A4 (en) 2018-11-02 2022-08-10 The Johns Hopkins University ADENOVIRAL CHIMERA TDP-43 PROTEINS
US20220136064A1 (en) 2019-02-09 2022-05-05 King Abdullah University Of Science And Technology Compositions and methods for cancer diagnosis and prognosis
CA3142777A1 (en) 2019-06-21 2020-12-24 Vaccinex, Inc. Combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy
EP3999083A4 (en) 2019-07-18 2023-07-26 Direct Biologics LLC Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
JP2023521837A (ja) 2020-04-14 2023-05-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 大きな配列の汎コロナウイルスワクチン組成物
US11225508B1 (en) 2020-09-23 2022-01-18 The University Of North Carolina At Chapel Hill Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
JP2023554589A (ja) 2020-11-27 2023-12-28 ジェネラル ナノセラピューティクス エルエルシー 免疫媒介性疾患の治療のための方法及び組成物
US20230279442A1 (en) 2021-12-15 2023-09-07 Versitech Limited Engineered cas9-nucleases and method of use thereof
KR102436232B1 (ko) * 2022-01-17 2022-08-25 주식회사 세명하이트 원통형 필터 제조방법 및 이에 따라 제조된 원통형 필터
US20250228940A1 (en) 2022-03-11 2025-07-17 Yale University Compositions and methods for efficient and stable genetic modification of eukaryotic cells
US20250161360A1 (en) 2022-05-10 2025-05-22 Yale University Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
KR102736561B1 (ko) * 2022-06-03 2024-12-02 현대제철 주식회사 전기로
KR102751454B1 (ko) * 2022-06-03 2025-01-10 현대제철 주식회사 전기로
KR102777625B1 (ko) * 2022-07-29 2025-03-11 현대제철 주식회사 전기로
KR102829902B1 (ko) * 2022-07-29 2025-07-04 현대제철 주식회사 전기로
KR102752443B1 (ko) * 2022-08-26 2025-01-09 현대제철 주식회사 전기로
KR102793154B1 (ko) * 2022-08-26 2025-04-07 현대제철 주식회사 전기로
WO2024064824A2 (en) 2022-09-21 2024-03-28 Yale University Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
US20240158490A1 (en) 2022-11-11 2024-05-16 Jeff R. Peterson Gout flare prevention methods using il-1beta blockers
KR102799788B1 (ko) * 2022-11-29 2025-04-22 현대제철 주식회사 전기로용 저취교반장치 및 이를 포함하는 전기로
WO2024155821A1 (en) 2023-01-18 2024-07-25 Yale University Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
WO2024226829A2 (en) 2023-04-26 2024-10-31 Yale University Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
WO2024238656A1 (en) 2023-05-15 2024-11-21 Yale Univeristy Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers
WO2025158400A1 (en) 2024-01-24 2025-07-31 Yale University Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US848422A (en) * 1905-06-23 1907-03-26 Frank Wynne Method of maintaining or increasing the fluidity of molten or semimolten materials by means of electricity.
US1339428A (en) * 1916-03-24 1920-05-11 Ludlum Electric Furnace Corp Method of operating an electric furnace

Also Published As

Publication number Publication date
DE1952407B2 (de) 1971-03-11
GB1252310A (enExample) 1971-11-03
JPS4829422B1 (enExample) 1973-09-10
DE1952407A1 (de) 1970-08-20
SE364311B (enExample) 1974-02-18
FR1601438A (enExample) 1970-08-24
US3610795A (en) 1971-10-05
LU59646A1 (enExample) 1970-01-12
BE739974A (enExample) 1970-03-16
ES372628A1 (es) 1971-11-01

Similar Documents

Publication Publication Date Title
BR6913348D0 (pt) Forno eletrico aperfeicoado para a fusao continua de produtos solidos
BR7407915A (pt) Aparelho aperfeicoado para preparar iogurte
BE743172A (fr) Element chauffant pour un four electrique
BR7108507D0 (pt) Bastidor para montagem de aparelhos eletricos intercambiaveis
BE764474A (fr) Four electrique perfectionne de fusion a haute
BR6913734D0 (pt) Forno comportando uma bacia para material fundido
BR7508289A (pt) Dispositivo para carregar forno eletrico de fusao
BR7806617A (pt) Forno para processar produtos alimenticios
BR7607417A (pt) Forno de producao continua para aquecimento de pecas circulares
BR7502270A (pt) Cadinho rotativo para forno de fusao
BR6908455D0 (pt) Aparelho para fazer produtos termoplasticos celulares
IT1051092B (it) Forno di cokerizzazione
BR7606626A (pt) Forno de inducao
BR7017979D0 (pt) Forno tunel chamado de abobada suspensa
BR7406499D0 (pt) Forno de reducao fechado aperfeicoado
BR7108002D0 (pt) Forno de reverbero
BR7408790D0 (pt) Dispositivo para movimento e distribuicao da carga em um forno eletrico de fusao
BR7107477D0 (pt) Material em folha para a blindagem de cabos eletricos
BR6906352D0 (pt) Aparelho para marcacao por extenceis de produtos em movimento
BR7105035D0 (pt) Forno eletrico trifasico para a producao de aluminio silicio
BR7108015D0 (pt) Forno tunel aperfeicoado para aquecimento de folhas de vidro
ES174738Y (es) Dispositivo perfeccionado para unir por sus extremos las cajas para aparatos electricos.
BR6906972D0 (pt) Unidade de barbear aperfeicoado para barbeador eletrico
FR1459053A (fr) Sectionneur de terre
BR7108506D0 (pt) Bastidor metalico para montagem de aparelhos eletricos intercambiaveis